Clinical trial
Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)
NCT07211841 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2025
- Completion date
- April 30, 2029
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biomarkers / blood, glioblastoma, mri spectroscopy, tumor microenvironment